- Home
- KINS vs FBRX Comparison
KINS vs FBRX Comparison
Compare KINS & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KINS
- FBRX
- Stock Information
- Founded
- KINS 1886
- FBRX N/A
- Country
- KINS United States
- FBRX United States
- Employees
- KINS N/A
- FBRX N/A
- Industry
- KINS Property-Casualty Insurers
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- KINS Finance
- FBRX Health Care
- Exchange
- KINS Nasdaq
- FBRX Nasdaq
- Market Cap
- KINS 189.6M
- FBRX 170.0M
- IPO Year
- KINS N/A
- FBRX N/A
- Fundamental
- Price
- KINS $14.39
- FBRX $19.84
- Analyst Decision
- KINS
- FBRX Strong Buy
- Analyst Count
- KINS 0
- FBRX 3
- Target Price
- KINS N/A
- FBRX $68.00
- AVG Volume (30 Days)
- KINS 134.7K
- FBRX 88.3K
- Earning Date
- KINS 11-06-2025
- FBRX 11-14-2025
- Dividend Yield
- KINS 1.40%
- FBRX N/A
- EPS Growth
- KINS 69.11
- FBRX N/A
- EPS
- KINS 2.26
- FBRX N/A
- Revenue
- KINS $198,583,138.00
- FBRX N/A
- Revenue This Year
- KINS $37.94
- FBRX N/A
- Revenue Next Year
- KINS $8.63
- FBRX N/A
- P/E Ratio
- KINS $6.31
- FBRX N/A
- Revenue Growth
- KINS 32.70
- FBRX N/A
- 52 Week Low
- KINS $11.65
- FBRX $4.90
- 52 Week High
- KINS $22.40
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- KINS 45.05
- FBRX 72.69
- Support Level
- KINS $13.90
- FBRX $13.42
- Resistance Level
- KINS $14.78
- FBRX $14.74
- Average True Range (ATR)
- KINS 0.54
- FBRX 1.51
- MACD
- KINS -0.09
- FBRX 0.66
- Stochastic Oscillator
- KINS 25.12
- FBRX 88.07
About KINS Kingstone Companies Inc.
Kingstone Companies Inc is a multi-line regional property and casualty insurance holding company. It offers insurance policies to small and mid-sized businesses as well as to individuals.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).